Form 4: iRhythm Technologies Director Mark Rubash Boosts Stake with RSU Grant

iRhythm Technologies, Inc. Director Mark J. Rubash has acquired 1,358 shares of common stock through a Restricted Stock Unit (RSU) grant, increasing his total beneficial ownership to 13,788 shares.

Summary

• Mark J. Rubash, a Director of iRhythm Technologies, Inc. (IRTC), acquired 1,358 shares of common stock.
• The acquisition occurred on May 28, 2025, through a grant of Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of IRTC Common Stock, with an acquisition price of $0.
• Following this transaction, Mr. Rubash's total beneficial ownership in iRhythm Technologies, Inc. stands at 13,788 shares.
• The RSUs are set to vest on the earlier of one year after the grant date or the date of the company's next annual meeting.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates increased insider ownership and alignment of interests, which is generally viewed favorably by investors, though it's a routine compensation event.

Positives

• Increases the director's direct beneficial ownership in the company, aligning his interests with those of shareholders.
• The grant of Restricted Stock Units (RSUs) is a common form of equity compensation, indicating ongoing commitment and incentivization for the director.

Future Outlook

The acquired Restricted Stock Units (RSUs) are scheduled to vest on the earlier of one year after the grant date (May 28, 2025) or the date of the company's next annual meeting, indicating future share issuance upon vesting.

Industry Context

This Form 4 filing reflects a routine equity compensation grant to a director, a common practice across publicly traded companies to align management and board interests with shareholder value, particularly in the medical technology and healthcare diagnostics sector where iRhythm Technologies operates.

Related Party Transactions

• The acquisition of 1,358 Restricted Stock Units by Director Mark J. Rubash constitutes a related party transaction, as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased equity ownership.

Next Steps

• Vesting of the 1,358 Restricted Stock Units (RSUs) on the earlier of one year after the grant date (May 28, 2025) or the date of the company's next annual meeting.

Key Dates

Recommendation

Keywords

iRhythm Technologies, IRTC, SEC Form 4, Insider Trading, Director Stock Grant, Restricted Stock Units, RSU, Equity Compensation, Beneficial Ownership, Mark J. Rubash